Abstract:Background: Information extraction from microarrays has not yet been widely used in diagnostic or prognostic decision-support systems, due to the diversity of results produced by the available techniques, their instability on different data sets and the inability to relate statistical significance with biological relevance. Thus, there is an urgent need to address the statistical framework of microarray analysis and identify its drawbacks and limitations, which will enable us to thoroughly compare methodologies under the same experimental set-up and associate results with confidence intervals meaningful to clinicians. In this study we consider gene-selection algorithms with the aim to reveal inefficiencies in performance evaluation and address aspects that can reduce uncertainty in algorithmic validation. Results: A computational study is performed related to the performance of several gene selection methodologies on publicly available microarray data. Three basic types of experimental scenarios are evaluated, i.e. the independent test-set and the 10-fold cross-validation (CV) using maximum and average performance measures. Feature selection methods behave differently under different validation strategies. The performance results from CV do not mach well those from the independent test-set, except for the support vector machines (SVM) and the least squares SVM methods. However, these wrapper methods achieve variable (often low) performance, whereas the hybrid methods attain consistently higher accuracies. The use of an independent test-set within CV is important for the evaluation of the predictive power of algorithms. The optimal size of the selected gene-set also appears to be dependent on the evaluation scheme. The consistency of selected genes over variation of the training-set is another aspect important in reducing uncertainty in the evaluation of the derived gene signature. In all cases the presence of outlier samples can seriously affect algorithmic performance. Conclusion: Multiple parameters can influence the selection of a gene-signature and its predictive power, thus possible biases in validation methods must always be accounted for. This paper illustrates that independent test-set evaluation reduces the bias of CV, and case-specific measures reveal stability characteristics of the gene-signature over changes of the training set. Moreover, frequency measures on gene selection address the algorithmic consistency in selecting the same gene signature under different training conditions. These issues contribute to the development of an objective evaluation framework and aid the derivation of statistically consistent gene signatures that could eventually be correlated with biological relevance. The benefits of the proposed framework are supported by the evaluation results and methodological comparisons performed for several gene-selection algorithms on three publicly available datasets.

A two step method to identify clinical outcome relevant genes with microarray data.

Identification of potential biomarkers with colorectal cancer based on bioinformatics analysis and machine learning

Biomarker Discovery To Improve Prediction Of Breast Cancer Survival: Using Gene Expression Profiling, Meta-Analysis, And Tissue Validation

Identification of glioma cancer-alerted gene markers based on a diagnostic outcome correlation analysis preferential approach.

Selection of interdependent genes via dynamic relevance analysis for cancer diagnosis.

A Robust Hybrid Approach Based on Estimation of Distribution Algorithm and Support Vector Machine for Hunting Candidate Disease Genes.

Outcome prediction based on microarray analysis: a critical perspective on methods

A Robust Statistical Procedure to Discover Expression Biomarkers Using Microarray Genomic Expression Data.

Identifying Oncogenes As Features for Clinical Cancer Prognosis by Bayesian Nonparametric Variable Selection Algorithm

On Gene Selection and Classification for Cancer Microarray Data Using Multi-Step Clustering and Sparse Representation

Gene selection and classification for cancer microarray data based on machine learning and similarity measures

Incorporating gene co-expression network in identification of cancer prognosis markers

Novel Hybrid Method for Gene Selection and Cancer Prediction

Ensemble gene selection for cancer classification

Very Important Pool (VIP) genes – an application for microarray-based molecular signatures

Signature Genes Selection and Functional Analysis of Phenotypes: A Comparative Study

A Survey of Gene Selection and Classification Techniques Based on Cancer Microarray Data Analysis

A Novel Method for Gene Selection and Cancer Classification

Maximizing Biomarker Discovery by Minimizing Gene Signatures

Gene selection for cancer classification using a hybrid of univariate and multivariate feature selection methods

Regularized Binormal ROC Method in Disease Classificationusing Microarray Data.